Literature DB >> 18275380

Mechanism of eukaryotic homologous recombination.

Joseph San Filippo1, Patrick Sung, Hannah Klein.   

Abstract

Homologous recombination (HR) serves to eliminate deleterious lesions, such as double-stranded breaks and interstrand crosslinks, from chromosomes. HR is also critical for the preservation of replication forks, for telomere maintenance, and chromosome segregation in meiosis I. As such, HR is indispensable for the maintenance of genome integrity and the avoidance of cancers in humans. The HR reaction is mediated by a conserved class of enzymes termed recombinases. Two recombinases, Rad51 and Dmc1, catalyze the pairing and shuffling of homologous DNA sequences in eukaryotic cells via a filamentous intermediate on ssDNA called the presynaptic filament. The assembly of the presynaptic filament is a rate-limiting process that is enhanced by recombination mediators, such as the breast tumor suppressor BRCA2. HR accessory factors that facilitate other stages of the Rad51- and Dmc1-catalyzed homologous DNA pairing and strand exchange reaction have also been identified. Recent progress on elucidating the mechanisms of action of Rad51 and Dmc1 and their cohorts of ancillary factors is reviewed here.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18275380     DOI: 10.1146/annurev.biochem.77.061306.125255

Source DB:  PubMed          Journal:  Annu Rev Biochem        ISSN: 0066-4154            Impact factor:   23.643


  758 in total

1.  Sae2 antagonizes Rad9 accumulation at DNA double-strand breaks to attenuate checkpoint signaling and facilitate end resection.

Authors:  Tai-Yuan Yu; Michael T Kimble; Lorraine S Symington
Journal:  Proc Natl Acad Sci U S A       Date:  2018-12-03       Impact factor: 11.205

2.  Assaying break and nick-induced homologous recombination in mammalian cells using the DR-GFP reporter and Cas9 nucleases.

Authors:  Lianne E M Vriend; Maria Jasin; Przemek M Krawczyk
Journal:  Methods Enzymol       Date:  2014       Impact factor: 1.600

3.  Distinct roles of FANCO/RAD51C protein in DNA damage signaling and repair: implications for Fanconi anemia and breast cancer susceptibility.

Authors:  Kumar Somyajit; Shreelakshmi Subramanya; Ganesh Nagaraju
Journal:  J Biol Chem       Date:  2011-12-13       Impact factor: 5.157

4.  PTEN loss compromises homologous recombination repair in astrocytes: implications for glioblastoma therapy with temozolomide or poly(ADP-ribose) polymerase inhibitors.

Authors:  Brian McEllin; Cristel V Camacho; Bipasha Mukherjee; Brandon Hahm; Nozomi Tomimatsu; Robert M Bachoo; Sandeep Burma
Journal:  Cancer Res       Date:  2010-06-08       Impact factor: 12.701

Review 5.  What goes on must come off: phosphatases gate-crash the DNA damage response.

Authors:  Dong-Hyun Lee; Dipanjan Chowdhury
Journal:  Trends Biochem Sci       Date:  2011-09-18       Impact factor: 13.807

Review 6.  Charity begins at home: non-coding RNA functions in DNA repair.

Authors:  Dipanjan Chowdhury; Young Eun Choi; Marie Eve Brault
Journal:  Nat Rev Mol Cell Biol       Date:  2013-02-06       Impact factor: 94.444

Review 7.  Non-homologous end joining: emerging themes and unanswered questions.

Authors:  Sarvan Kumar Radhakrishnan; Nicholas Jette; Susan P Lees-Miller
Journal:  DNA Repair (Amst)       Date:  2014-02-26

8.  DNA Crossover Motifs Associated with Epigenetic Modifications Delineate Open Chromatin Regions in Arabidopsis.

Authors:  Shay Shilo; Cathy Melamed-Bessudo; Yanniv Dorone; Naama Barkai; Avraham A Levy
Journal:  Plant Cell       Date:  2015-09-17       Impact factor: 11.277

Review 9.  The multifaceted functions of sirtuins in cancer.

Authors:  Angeliki Chalkiadaki; Leonard Guarente
Journal:  Nat Rev Cancer       Date:  2015-09-18       Impact factor: 60.716

10.  Hepatocyte Growth Factor Improves the Therapeutic Efficacy of Human Bone Marrow Mesenchymal Stem Cells via RAD51.

Authors:  Eun Ju Lee; Injoo Hwang; Ji Yeon Lee; Jong Nam Park; Keun Cheon Kim; Gi-Hwan Kim; Chang-Mo Kang; Irene Kim; Seo-Yeon Lee; Hyo-Soo Kim
Journal:  Mol Ther       Date:  2017-12-19       Impact factor: 11.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.